Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesMeeting of the MindsTraining Academy
Conference CoverageConference Listing
Publications
Continuing Education
Case-Based Digest Rx Road MapWebinarsCancer Summary SlidesMPN Symptom ManagementEvents
SubscribePartners
Brain Cancer
Breast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head and Neck Cancers
HematologyHematologyHematologyHematologyHematologyHematology
Lung Cancer
Pediatric Cancer
Sarcomas
Skin CancerSkin Cancer
Advanced Practice Corner Logo
    Brain Cancer
    Breast CancerBreast Cancer
    Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
    Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
    Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
    Head and Neck Cancers
    HematologyHematologyHematologyHematologyHematologyHematology
    Lung Cancer
    Pediatric Cancer
    Sarcomas
    Skin CancerSkin Cancer
    Advanced Practice Corner Logo
        • Publications
        • Subscribe
        • Partners
      Advertisement

      Patients and Caregivers Withhold Cancer-Related Information

      April 29, 2019
      By Brielle Benyon
      Article

      Despite stating that they tell their loved ones everything, there are some details that patients with gynecologic cancer tend to leave out.

      Patients with gynecologic cancer and their caregivers may claim that they tell their healthcare providers everything, but there are still some issues that go undiscussed, according to recent research conducted across multiple institutions and published in the Oncology Nursing Forum.

      Researchers conducted semi-structured phone interviews with 18 patients in treatment for their first appearance of ovarian, uterine, or endometrial cancer who were between treatment cycles 2 and 5, as well as 16 supporters (89% of participants were patient-supporter dyads).

      “We were looking at what information the patients were holding back,” said study co-author Kathryn Greene, of Rutgers University Department of Communication. “The interaction with healthcare providers during treatment can increase or decrease uncertainty.”

      Ultimately, there were 2 main themes observed in the participant interviews. The first was that everything was easy to share with their caregiver and provider. “This shows up in almost all the cases. Almost everyone says they’re saying everything,” Greene said.

      Patients who said that they shared everything often noted that their treatment was going well, and they were comfortable discussing any adverse events (AEs) they were experiencing. They also focused on the quality relationships they had with their caregivers and healthcare providers. “There’s no secrets. We share everything with the doctor,” one participant — a husband of patient – said during the interviews.

      Additionally, all healthcare providers who were interviewed claimed that their patients told them everything and reported having good relationships with them.

      The second theme that emerged were statements like “Nothing is held back, except…,” where patients and their caregivers claimed that they were mostly open with each other and the providers, but there were some topics that they did not bring up.

      “We’re always interested in the exceptions, and these come up spontaneously,” Greene said.

      Some patients reported that they were embarrassed of sharing updates regarding constipation or vaginal discharge. “You know, there’s things that are sort of more just, like from a woman’s perspective, like the whole constipation thing was a little embarrassing to me,” one patient said.

      These findings are similar to those presented at the 2019 ONS Annual Congress that said women with ovarian cancer who had a high symptom severity were 37% less likely to appropriately communicate issues compared to women with a lower symptom score.

      “It’s important health-related information [to share],” Greene said, emphasizing that any AEs a patient is experiencing should be brought up with her healthcare provider.

      Both patients and their caregivers also reported a hesitancy to bring up their fears and concerns regarding disease prognosis and the future. People often don’t want to bring these up to avoid adding additional stress to their loved ones in a time that is already so scary and uncertain, Greene said.

      “Both support people and patients are saying that these are things that they don’t want to discuss in front of the other person,” she added. “Independently they share these concerns, but neither want to bring them up.”

      In talking with patients and caregivers separately, providers—including oncology nurses–may develop a better understanding of their fears and worries, and guide them toward the proper psychosocial supports, if applicable. “We need to probe these interactions separately,” Greene said.

      Moving forward, the researchers are hoping to expand their study to a broader cohort, including healthcare professionals, and develop an intervention to ensure that crucial topics are being discussed.

      Reference

      Checton MG, Venetis MK, Catona D, Bontempo A, et al. Patients with gyecologic cancer and supporters' reports of sharing (and holding back) cancer-related information during oncology visits. Oncology Nursing Forum. 2019

      Newsletter

      Stay up to date on recent advances in oncology nursing and patient care.

      Subscribe Now!
      Recent Videos
      Cancer-Related Cognitive Impairment
      Elizabeth Cullen
      Christine Wylie
      Eric Zack
      Donna Catamero
      Related Content

      Acupuncture May Reduce Hot Flashes in Patients With Breast Cancer Undergoing Endocrine Therapy

      Acupuncture May Reduce Hot Flashes in Patients With Breast Cancer Undergoing Endocrine Therapy

      Roman Fabbricatore
      July 29th 2024
      Article

      Findings from this study also demonstrate statistically meaningful improvements in breast cancer–specific quality of life and endocrine symptoms with acupuncture.


      Oncology Nursing Stories: Acupuncture Helps Thyroid Cancer Survivor Taper Opioid Use

      Oncology Nursing Stories: Acupuncture Helps Thyroid Cancer Survivor Taper Opioid Use

      Lindsay Fischer
      December 15th 2022
      Podcast

      In this episode of "The Vitals," Heather Jackson, PhD, FNP-BC, NEA-BC, FAANP, shares her experience helping a patient reduce their opioid use through acupuncture treatments.


      Informing Patients With Cancer About the Potential Impact of Immunotherapy on Pregnancy

      Informing Patients With Cancer About the Potential Impact of Immunotherapy on Pregnancy

      Iryna Singh, NP
      July 23rd 2024
      Article

      An expert explores the complexities of immunotherapy during pregnancy, highlighting risks to the fetus and the crucial role of oncology nurses in patient education and management.


      Nursing Perspectives on Managing Toxicities With ADCs in Metastatic Gastric and Breast Cancers

      Nursing Perspectives on Managing Toxicities With ADCs in Metastatic Gastric and Breast Cancers

      Lindsay Fischer
      September 1st 2022
      Podcast

      In this episode of "The Vitals," Sarah Donahue, MPH, NP, AOCNP; Jamie Carroll, APRN, CNP, MSN; Theresa Wicklin Gillespie, PhD, MA, RN, FAAN; and Elizabeth Prechtel-Dunphy, DNP, RN, ANP-BC, AOCN, exchange clinical pearls for treating patients receiving antibody-drug conjugates.


      Hearing loss concept. Woman and sound waves illustration on light blue background, closeup: © New Africa - stock.adobe.com

      Increasing Awareness of Audiovestibular Adverse Events From Immune Checkpoint Inhibitors

      Iryna Singh, NP
      July 16th 2024
      Article

      Oncology nurses play a critical role in identifying and managing rare audiovestibular complications associated with immune checkpoint inhibitors to prevent permanent hearing loss and improve patients' quality of life.


      Rx Road Map: Enfortumab Vedotin (Padcev)

      Rx Road Map: Enfortumab Vedotin (Padcev)

      Srigowri Kota, MSN, BA, RN, APN, AGNP-C, OCN
      July 2nd 2024
      Article

      Srigowri Kota, MSN, BA, APRN, AGNP-C, AOCNP, provides an in-depth look at enfortumab vedotin for the treatment of patients with urothelial cancer in a downloadable reference sheet.

      Related Content

      Acupuncture May Reduce Hot Flashes in Patients With Breast Cancer Undergoing Endocrine Therapy

      Acupuncture May Reduce Hot Flashes in Patients With Breast Cancer Undergoing Endocrine Therapy

      Roman Fabbricatore
      July 29th 2024
      Article

      Findings from this study also demonstrate statistically meaningful improvements in breast cancer–specific quality of life and endocrine symptoms with acupuncture.


      Oncology Nursing Stories: Acupuncture Helps Thyroid Cancer Survivor Taper Opioid Use

      Oncology Nursing Stories: Acupuncture Helps Thyroid Cancer Survivor Taper Opioid Use

      Lindsay Fischer
      December 15th 2022
      Podcast

      In this episode of "The Vitals," Heather Jackson, PhD, FNP-BC, NEA-BC, FAANP, shares her experience helping a patient reduce their opioid use through acupuncture treatments.


      Informing Patients With Cancer About the Potential Impact of Immunotherapy on Pregnancy

      Informing Patients With Cancer About the Potential Impact of Immunotherapy on Pregnancy

      Iryna Singh, NP
      July 23rd 2024
      Article

      An expert explores the complexities of immunotherapy during pregnancy, highlighting risks to the fetus and the crucial role of oncology nurses in patient education and management.


      Nursing Perspectives on Managing Toxicities With ADCs in Metastatic Gastric and Breast Cancers

      Nursing Perspectives on Managing Toxicities With ADCs in Metastatic Gastric and Breast Cancers

      Lindsay Fischer
      September 1st 2022
      Podcast

      In this episode of "The Vitals," Sarah Donahue, MPH, NP, AOCNP; Jamie Carroll, APRN, CNP, MSN; Theresa Wicklin Gillespie, PhD, MA, RN, FAAN; and Elizabeth Prechtel-Dunphy, DNP, RN, ANP-BC, AOCN, exchange clinical pearls for treating patients receiving antibody-drug conjugates.


      Hearing loss concept. Woman and sound waves illustration on light blue background, closeup: © New Africa - stock.adobe.com

      Increasing Awareness of Audiovestibular Adverse Events From Immune Checkpoint Inhibitors

      Iryna Singh, NP
      July 16th 2024
      Article

      Oncology nurses play a critical role in identifying and managing rare audiovestibular complications associated with immune checkpoint inhibitors to prevent permanent hearing loss and improve patients' quality of life.


      Rx Road Map: Enfortumab Vedotin (Padcev)

      Rx Road Map: Enfortumab Vedotin (Padcev)

      Srigowri Kota, MSN, BA, RN, APN, AGNP-C, OCN
      July 2nd 2024
      Article

      Srigowri Kota, MSN, BA, APRN, AGNP-C, AOCNP, provides an in-depth look at enfortumab vedotin for the treatment of patients with urothelial cancer in a downloadable reference sheet.

      Latest Conference Coverage

      Relacorilant Combo Boosts PFS in Resistant Ovarian Cancer

      Nivolumab/Ipilimumab To Be New MSI-H/dMMR mCRC Standard of Care

      T-DXd PFS Benefit Significant Across HR+, HER2-Low Breast Cancer Mutations

      AI Tool May Predict Response, Resistance in Advanced RCC

      View More Latest Conference Coverage
      About Us
      Editorial Board
      Contact Us
      CancerNetwork.com
      CureToday.com
      OncLive.com
      TargetedOnc.com
      Advertise
      Privacy
      Terms & Conditions
      Do Not Sell My Information
      Contact Info

      2 Commerce Drive
      Cranbury, NJ 08512

      609-716-7777

      © 2025 MJH Life Sciences

      All rights reserved.